Kelley Dougherty - Head of Corporate Affairs — Teva Pharmaceuticals, North America - Teva Pharmaceuticals | LinkedIn
Kelley Dougherty - Head of Corporate Affairs — Teva Pharmaceuticals, North America - Teva Pharmaceuticals | LinkedIn
![Los fabricantes de medicamentos genéricos inflaron los precios hasta un 1000% en EEUU, según una demanda histórica Los fabricantes de medicamentos genéricos inflaron los precios hasta un 1000% en EEUU, según una demanda histórica](https://i.blogs.es/18f5c3/thought-catalog-567751-unsplash/1366_2000.jpg)
Los fabricantes de medicamentos genéricos inflaron los precios hasta un 1000% en EEUU, según una demanda histórica
TEVA REPORTS FIRST QUARTER 2020 FINANCIAL RESULTS • Revenues of $4.4 billion • GAAP diluted EPS of $0.06 • Non-GAAP dilute
Kelley Dougherty - Head of Corporate Affairs — Teva Pharmaceuticals, North America - Teva Pharmaceuticals | LinkedIn
Kelley Dougherty - Head of Corporate Affairs — Teva Pharmaceuticals, North America - Teva Pharmaceuticals | LinkedIn
![Teva reaches $925K settlement with Mississippi in price-fixing case—and it hopes other states will follow suit | Fierce Pharma Teva reaches $925K settlement with Mississippi in price-fixing case—and it hopes other states will follow suit | Fierce Pharma](https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1624461972/gavel.jpg/gavel.jpg?VersionId=t7mJqjySetYFuol_jqUGEOWLX1H41vHS)